Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Follow-on African Consortium for Tenofovir Studies (FACTS)
United States Agency for International Development (USAID)
Information provided by (Responsible Party):
CONRAD
ClinicalTrials.gov Identifier:
NCT01386294
First received: June 28, 2011
Last updated: June 16, 2014
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)